Pyridam Farma Tbk PT
IDX:PYFA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Chengdu Xuguang Electronics Co Ltd
SSE:600353
|
CN |
|
Korean Air Lines Co Ltd
KRX:003490
|
KR |
Pyridam Farma Tbk PT
Other Long-Term Assets
Pyridam Farma Tbk PT
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Other Long-Term Assets
Rp65.1B
|
CAGR 3-Years
57%
|
CAGR 5-Years
59%
|
CAGR 10-Years
35%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Other Long-Term Assets
Rp416.1B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
3%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Other Long-Term Assets
Rp221.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Other Long-Term Assets
Rp75B
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
6%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Other Long-Term Assets
Rp126.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Other Long-Term Assets
Rp175.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-2%
|
|
Pyridam Farma Tbk PT
Glance View
PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.
See Also
What is Pyridam Farma Tbk PT's Other Long-Term Assets?
Other Long-Term Assets
65.1B
IDR
Based on the financial report for Sep 30, 2025, Pyridam Farma Tbk PT's Other Long-Term Assets amounts to 65.1B IDR.
What is Pyridam Farma Tbk PT's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
35%
Over the last year, the Other Long-Term Assets growth was 208%. The average annual Other Long-Term Assets growth rates for Pyridam Farma Tbk PT have been 57% over the past three years , 59% over the past five years , and 35% over the past ten years .
